Cargando…

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements

Invasive pulmonary aspergillosis (IPA) has always been a challenging diagnosis and risk factors an important guide to investigate specific population, especially in Intensive Care Unit. Traditionally recognized risk factors for IPA have been haematological diseases or condition associated with sever...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montrucchio, G., Lupia, T., Lombardo, D., Stroffolini, G., Corcione, S., De Rosa, F. G., Brazzi, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441237/ https://www.ncbi.nlm.nih.gov/pubmed/34524562 http://dx.doi.org/10.1186/s13613-021-00923-4

Ejemplares similares

Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball
por: Montrucchio, G., et al.
Publicado: (2020)

Personalized stewardship and interdisciplinarity: key elements of COVID-19
por: Lupia, Tommaso, et al.
Publicado: (2021)

Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study
por: Corcione, Silvia, et al.
Publicado: (2021)

Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with?
por: Corcione, Silvia, et al.
Publicado: (2023)

A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold
por: Lupia, Tommaso, et al.
Publicado: (2022)

Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN)
por: Lupia, Tommaso, et al.
Publicado: (2022)

Poppies, Bloom
por: Lupia, Tommaso, et al.
Publicado: (2021)

Trichoderma spp.-Related Pneumonia: A Case Report in Heart–Lung Transplantation Recipient and a Systematic Literature Review
por: Burzio, Carlo, et al.
Publicado: (2023)

Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature
por: Burzio, Carlo, et al.
Publicado: (2023)

Bacterial and Viral Infections in Liver Transplantation: New Insights from Clinical and Surgical Perspectives
por: Shbaklo, Nour, et al.
Publicado: (2022)

New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU
por: Hamam, Joffrey, et al.
Publicado: (2021)

Aspergillosis in the ICU: The glass half-empty?
por: Crawford, S. W.
Publicado: (1996)

Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
por: Aberegg, Scott K., et al.
Publicado: (2021)

Invasive aspergillosis in a medical ICU: the spectrum of disease in 89 nonhaematology patients
por: Meersseman, W, et al.
Publicado: (2004)

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
por: Prattes, Juergen, et al.
Publicado: (2020)

Invasive Aspergillosis in Children: Update on Current Guidelines
por: Apsemidou, Athanasia, et al.
Publicado: (2018)

Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Antimicrobial Prophylaxis in Extracorporeal Membrane Oxygenation: Is the Debate Still Open?
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Ceftobiprole Perspective: Current and Potential Future Indications
por: Lupia, Tommaso, et al.
Publicado: (2021)

Systematic screening for COVID‐19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate
por: van Grootveld, Rebecca, et al.
Publicado: (2021)

Microbiological Non-Culture-Based Methods for Diagnosing Invasive Pulmonary Aspergillosis in ICU Patients
por: Scharmann, Ulrike, et al.
Publicado: (2023)

Giardiasis reactivation during severe SARS-CoV-2 infection
por: Lupia, Tommaso, et al.
Publicado: (2021)

Microbiome in the setting of burn patients: implications for infections and clinical outcomes
por: Corcione, Silvia, et al.
Publicado: (2020)

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians
por: Principe, Luigi, et al.
Publicado: (2022)

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2023)

Prognostic Scores and Azole-Resistant Aspergillus fumigatus in Invasive Aspergillosis from an Indian Respiratory Medicine ICU (ICU Patients with IA Suspicion)
por: Dabas, Yubhisha, et al.
Publicado: (2021)

New cephalosporins for the treatment of pneumonia in internal medicine wards
por: Lupia, Tommaso, et al.
Publicado: (2020)

Current State of the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplantation
por: Herrera, Sabina, et al.
Publicado: (2019)

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
por: Heldt, Sven, et al.
Publicado: (2017)

Infection Control in the Era of COVID-19: A Narrative Review
por: Shbaklo, Nour, et al.
Publicado: (2021)

1495. Aspergillosis Complicating Severe Influenza in ICU Patients: A Retrospective Cohort Study
por: Visek, Caitlin, et al.
Publicado: (2020)

Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients
por: Eigl, Susanne, et al.
Publicado: (2015)

Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS)
por: Corcione, Silvia, et al.
Publicado: (2022)

Pediatric Invasive Aspergillosis
por: Wattier, Rachel L., et al.
Publicado: (2016)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Reply to Aberegg and Wolfe: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
por: Loughlin, Laura, et al.
Publicado: (2021)

Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis
por: Beltrame, Anna, et al.
Publicado: (2023)

What’s new in invasive pulmonary aspergillosis in the critically ill
por: Koulenti, Despoina, et al.
Publicado: (2014)

SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_55q43bfejsvl6iucmtgbo9f60e